Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides

被引:16
作者
Heldler, P
Zohrabi-Kalantari, V
Calmels, T
Capet, M
Berrebi-Bertrand, I
Schwartz, JC
Stark, H
Link, A
机构
[1] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany
[2] Bioproject Biotech, F-35762 St Gregoire, France
[3] Univ Frankfurt, Inst Pharmaceut Chem, D-60349 Frankfurt, Germany
关键词
D O I
10.1016/j.bmc.2005.01.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have applied a fast and high-yielding method for the parallel amidation of 4-[4-(2-methoxyphenyl)piperazin-1-yl]butylamine yielding analogs of the partial dopamine receptor agonist BP 897. Using this amino scaffold prepared in solution and polymer-bound carboxylic acid equivalents, we have synthesized a series of high affinity dopamine D-3 receptor ligands. The novel compounds were obtained in good to excellent yield and purity. Biological evaluation included determination of binding affinities at hD(2S) and hD(3) receptor subtypes. From the 22 novel structures presented here, compound 4v showed high affinity (K-i (hD3) 1.6 nM) and a 136-fold preference for the D-3 receptor versus that for the D-2 receptor subtype. Our results suggest that this derivatization technique is a useful method to speed up structure-activity relationships studies on dopamine receptor subtype modulators. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2009 / 2014
页数:6
相关论文
共 15 条
[1]   Resin-supported labeling reagents [J].
Adamczyk, M ;
Fishpaugh, JR ;
Mattingly, PG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) :217-220
[2]   Interactive SAR studies:: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists [J].
Bettinetti, L ;
Schlotter, K ;
Hübner, H ;
Gmeiner, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) :4594-4597
[3]   Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function [J].
Bézard, E ;
Ferry, S ;
Mach, U ;
Stark, H ;
Leriche, L ;
Boraud, T ;
Gross, C ;
Sokoloff, P .
NATURE MEDICINE, 2003, 9 (06) :762-767
[4]   Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice [J].
Boeckler, F ;
Leng, A ;
Mura, A ;
Bettinetti, L ;
Feldon, J ;
Gmeiner, P ;
Ferger, B .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (06) :1025-1032
[5]   Polymer-assisted solution-phase synthesis of 2′-amido-2′-deoxyadenosine derivatives targeted at the NAD+-binding sites of parasite enzymes [J].
Golisade, A ;
Bressi, JC ;
Van Calenbergh, S ;
Gelb, MH ;
Link, A .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2000, 2 (05) :537-544
[6]   Distribution of dopamine D3 receptor expressing neurons in the human forebrain:: Comparison with D2 receptor expressing neurons [J].
Gurevich, EV ;
Joyce, JN .
NEUROPSYCHOPHARMACOLOGY, 1999, 20 (01) :60-80
[7]   N-(ω-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands [J].
Hackling, A ;
Ghosh, R ;
Perachon, S ;
Mann, A ;
Höltje, HD ;
Wermuth, CG ;
Schwartz, JC ;
Sippl, W ;
Sokoloff, P ;
Stark, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) :3883-3899
[8]  
Hackling AE, 2002, CHEMBIOCHEM, V3, P946, DOI 10.1002/1439-7633(20021004)3:10<946::AID-CBIC946>3.0.CO
[9]  
2-5
[10]   Antimalarial activity of N6-substituted adenosine derivatives (Part 2) [J].
Herforth, C ;
Wiesner, J ;
Franke, S ;
Golisade, A ;
Jomaa, H ;
Link, A .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2002, 4 (04) :302-314